Medacta International MiniMAX CEMENTLESS ANATOMICAL STEM, 12/14: for cementless use in total or p...
FDA Device Recall #Z-0196-2019 — Class II — November 15, 2017
Recall Summary
| Recall Number | Z-0196-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 15, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Medacta Usa Inc |
| Location | Memphis, TN |
| Product Type | Devices |
| Quantity | 837 units |
Product Description
Medacta International MiniMAX CEMENTLESS ANATOMICAL STEM, 12/14: for cementless use in total or partial hip arthroplasty in primary or revision surgery.
Reason for Recall
Complaint monitoring noted a trend of packaging being breached for the MiniMAX Stem.
Distribution Pattern
NC, ID, Belgium, Switzerland, Spain, Germany, Australia, France, Italy
Lot / Code Information
a) REF 01.13.100L, GTIN 07630030803130 b) REF 01.13.101L, GTIN 07630030803154 c) REF 01.13.102L, GTIN 07630030803178 d) REF 01.13.103L, GTIN 07630030803192 e) REF 01.13.104L, GTIN 07630030803215 f) REF 01.13.105L, GTIN 07630030803239 g) REF 01.13.106L, GTIN 07630030803253 h) REF 01.13.107L, GTIN 07630030803277 I) REF 01.13.108L, GTIN 07630030803291 j) REF 01.13.100R, GTIN 07630030803147 k) REF 01.13.101R, GTIN 07630030803161 l) REF 01.13.102R, GTIN 07630030803185 m) REF 01.13.103R, GTIN 07630030803208 n) REF 01.13.104R, GTIN 07630030803222 o) REF 01.13.105R, GTIN 07630030803246 p) REF 01.13.106R, GTIN 07630030803260 q) REF 01.13.107R, GTIN 07630030803284 r) REF 01.13.108R, GTIN 07630030803307 Lots produced with the old version of the packaging, including lot numbers less than 169041.
Other Recalls from Medacta Usa Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1401-2023 | Class II | MectaLIF ANTERIOR - Lag Plate Flush H12, REF 03... | Mar 8, 2023 |
| Z-1405-2023 | Class II | MectaLIF ANTERIOR - Antibackout Lag Cover, REF ... | Mar 8, 2023 |
| Z-1404-2023 | Class II | MectaLIF ANTERIOR - Lag Plate Flush H18, REF 03... | Mar 8, 2023 |
| Z-1402-2023 | Class II | MectaLIF ANTERIOR - Lag Plate Flush H14, REF 03... | Mar 8, 2023 |
| Z-1403-2023 | Class II | MectaLIF ANTERIOR - Lag Plate Flush H16, REF 03... | Mar 8, 2023 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.